![]() |
市场调查报告书
商品编码
1880632
天然可吸收缝合线市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032)Natural Absorbable Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受外科手术量增加和对生物相容性伤口闭合材料需求成长的推动,全球天然可吸收缝合线市场持续稳定扩张。根据最新估计,2024年该市场规模将达到9.218亿美元,主要得益于一般外科、妇科、心臟外科和骨科等领域的高使用率。人口老化和需要手术介入的慢性疾病盛行率不断上升,预计到2025年该市场规模将增长至9.592亿美元。到2032年,该市场预计将达到14.984亿美元,预测期内复合年增长率将达到6.6%。
天然可吸收缝线通常由取自健康绵羊肠道的纯化结缔组织製成,广泛用于内科手术。其生物降解性无需拆线,使其成为深部和难以触及的手术部位的理想选择。其良好的生物相容性和较低的组织反应使其在内科伤口管理中越来越优于不可吸收缝合线。
市场推动因素
人口老化加剧和手术量增加
全球老年人口的成长显着推动了市场成长,尤其是在老年人群中,心臟外科、骨科和一般外科手术更为常见。在这些情况下,天然可吸收缝线对于术后伤口闭合至关重要。例如,根据澳洲健康与福利研究所的报告,2021年至2022年间共进行了12,700例冠状动脉绕道手术(CABG)。同样,人们对整形手术的需求也不断增长。据国际美容整形外科学会称,2023年全球将记录超过352,000例男性女乳症手术,这将进一步推动缝线的使用。
市场限制因子
常用的伤口缝合替代方案
手术缝合器、组织黏合剂和合成可吸收缝线的普及正在逐渐限制天然缝线的使用。由聚乙醇酸(PGA)和聚乳酸(PLA)製成的合成产品具有更高的耐用性和可预测的吸收率。据Unicer Lifecare(2024)称,皮肤缝合器可显着缩短手术时间,并且是紧急伤口缝合的首选,这对天然可吸收缝合线的需求构成了挑战。
市场机会
新兴经济体医疗基础设施的扩张
发展中国家的医疗基础设施正在显着扩张,手术量也不断增加。世界各国政府都在大力投资新建医院、专科诊所和先进的外科部门。新南威尔斯州投资7.233亿澳元兴建的特威德谷医院(Tweed Valley Hospital)于2024年5月开业,就是一个医疗设施扩容支持市场成长的例证。
市场挑战
天然缝合线的併发症
由于羊肠线缝合线可能引起发炎反应并增加感染风险,外科医生正在转向合成缝合线。诸如抗拉强度差异、潜在的过敏反应以及易感染等问题限制了合成缝合线的广泛应用,尤其是在拥有严格感染控制规程的先进医疗机构中。
严格的监理审批要求
製造商必须遵守美国FDA和欧洲药品管理局(EMA)等机构的严格规定。广泛的临床验证和严格的品质文件会延长研发时间并增加成本,这对寻求推出新型天然缝线产品的中小型企业构成挑战。
市场趋势
铬製Katgut缝合线的应用日益广泛
铬製Katgut缝合线因其更高的抗拉强度和更低的感染风险(透过铬盐溶液处理实现)而得到越来越广泛的应用。其低成本和可生物降解性使其成为各种外科手术的首选。
微创手术中应用日益广泛
由于天然可吸收缝线具有吸收顺畅、生物相容性好以及适用于内部组织缝合等优点,进行腹腔镜手术和妇科手术的外科医生越来越多地选择使用天然可吸收缝线。
北美 - 市场领导者(2024 年:3.334 亿美元)
北美在 2024 年以 36.16% 的市占率领先,这主要得益于其先进的医疗基础设施和高手术量。在 FIME 2025 等医疗展会上,Dolphin Satures 展示了其天然可吸收缝线,进一步提高了产品知名度,并促进了该地区的采用。
欧洲
欧洲占了较大的市场占有率,这主要归功于其骨科、心臟和普通外科手术量巨大。预计2022年英格兰将记录超过42,000例骨科手术,显示该地区需求强劲。
亚太地区
由于医疗旅游、手术量增加以及印度、中国和东南亚医院基础设施的扩建,亚太地区预计将以最高的复合年增长率增长。
拉丁美洲、中东和非洲
成长保持稳定,这得益于手术量增加以及当地医疗机构扩大采用低成本天然缝合线。
The global natural absorbable sutures market continues to expand steadily, fueled by rising surgical volumes and increasing demand for biocompatible wound closure materials. According to the latest estimates, the market was valued at USD 921.8 million in 2024, supported by strong usage in general surgery, gynecology, cardiology, and orthopedics. The value is projected to rise to USD 959.2 million in 2025, driven by a growing geriatric population and increasing prevalence of chronic diseases requiring surgical intervention. By 2032, the market is expected to reach USD 1,498.4 million, reflecting a healthy CAGR of 6.6% during the forecast period.
Natural absorbable sutures, typically made from purified connective tissue obtained from healthy sheep intestines, are widely used for internal surgical procedures. Their ability to biodegrade within the body eliminates the need for suture removal, making them ideal for deep and difficult-to-access surgical sites. Higher biocompatibility and reduced tissue reaction further enhance their preference over non-absorbable alternatives in internal wound management.
Market Drivers
Growing Geriatric Population & Rising Surgical Procedures
The global increase in the elderly population is significantly boosting market growth, as older individuals undergo a higher percentage of cardiac surgeries, orthopedic procedures, and general surgeries. Natural absorbable sutures are crucial for postoperative wound closure in these cases. For example, the Australian Institute of Health and Welfare reported 12,700 coronary artery bypass graft (CABG) procedures performed between 2021 and 2022. Similarly, the demand for aesthetic surgeries is growing, with the International Society of Aesthetic Plastic Surgery recording over 352,000 gynecomastia procedures globally in 2023, further driving suture usage.
Market Restraints
Rising Use of Alternative Wound Closure Methods
The adoption of surgical staplers, tissue adhesives, and synthetic absorbable sutures is increasingly limiting the uptake of natural sutures. Synthetic options made from PGA and PLA offer improved durability and predictable absorption rates. According to Unisur Lifecare (2024), skin staplers significantly reduce operating time and are preferred in emergency wound closures, challenging the demand for natural absorbable sutures.
Market Opportunities
Expanding Healthcare Infrastructure in Emerging Economies
Developing nations are witnessing substantial medical infrastructure expansion and rising surgical volumes. Governments are investing heavily in new hospitals, specialty clinics, and advanced surgical departments. The USD 723.3 million investment by New South Wales into the Tweed Valley Hospital, opened in May 2024, is an example of increasing institutional capacities that support market growth.
Market Challenges
Complications Associated with Natural Sutures
Catgut-based sutures may trigger inflammatory reactions and increase infection risk, leading surgeons to shift toward synthetic options. Variations in tensile strength, potential hypersensitivity, and higher infection susceptibility limit adoption, particularly in advanced healthcare settings with stringent infection-control protocols.
Stringent Regulatory Approval Requirements
Manufacturers must comply with rigorous regulations from authorities such as the U.S. FDA and EMA. Extensive clinical validation and strict quality documentation extend development timelines and increase costs, creating challenges for smaller companies aiming to launch new natural suture products.
Market Trends
Growing Adoption of Chromic Catgut Sutures
Chromic catgut sutures are increasingly used due to their improved tensile strength and reduced infection risk, achieved through the treatment of sutures in chromic salt solutions. Their low cost and biodegradability make them a preferred option in multiple surgical procedures.
Rising Use in Minimally Invasive Surgeries
Surgeons performing laparoscopic and gynecological procedures are increasingly opting for natural absorbable sutures due to their smooth absorption profile, biocompatibility, and suitability for internal tissue closures.
North America - Market Leader (USD 333.4 Million in 2024)
North America dominated the market in 2024 with 36.16% share, supported by advanced healthcare infrastructure and high surgical volumes. Medical events such as FIME 2025, where Dolphin Sutures showcased its natural dissolvable sutures, further enhance product visibility and regional adoption.
Europe
Europe holds a significant share driven by a high burden of orthopedic, cardiac, and general surgeries. More than 42,000 orthopedic operations were recorded in England in 2022, demonstrating strong regional demand.
Asia Pacific
Asia Pacific is projected to grow at the highest CAGR due to medical tourism, rising surgical volumes, and expanding hospital infrastructure across India, China, and Southeast Asia.
Latin America & Middle East/Africa
Growth remains steady, supported by increasing surgical procedures and higher adoption of low-cost natural sutures in local healthcare facilities.
Conclusion
With global value increasing from USD 921.8 million in 2024 to USD 1,498.4 million by 2032, the natural absorbable sutures market is poised for steady growth. Rising surgical demand, aging populations, and improvements in medical infrastructure will continue to drive expansion, despite challenges posed by alternative wound closure methods and regulatory complexities.
Segmentation By Product, Material, Application, End-user, and Region
By Product * Monofilament
By Material * Catgut Chromic Sutures
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (by Product, by Material, by Application, by End-user, and by Country/Sub-Region)